US Army awards JLTV EMD contracts
The US Army has announced the award of three contracts for the engineering and manufacturing development (EMD) phase of the Joint Light Tactical Vehicle (JLTV) programme.
AM General, Lockheed Martin and Oshkosh Corporation were awarded EMD contracts for the JLTV project, which aims to replace many of the US military’s aged HMMWVs with a lightweight vehicle offering greater protection, mobility and transportability.
JLTV is a joint service programme between the US Army and Marine Corps with the army designated as the lead service.
The contract awards follow the Department of Defense's formal approval of the programme to enter the EMD
Already have an account? Log in
Want to keep reading this article?
Read this Article
Get access to this article with a Free Basic Account
- Original curated content, daily across air, land and naval domains
- 2 free stories per week
- Daily news round-up email service
- Access to all Decisive Edge email newsletters
Unlimited Access
Access to all our premium news as a Premium News 365 Member. Corporate subscriptions available.
- Original curated content, daily across air, land and naval domains
- 14-day free trial (cancel at any time)
- Unlimited access to all published premium news
More from Land Warfare
-
Taiwan continues to modernise its army with indigenous products
The island’s government has pushed through increased defence spending on new equipment, including the development of new rifles and the introduction of new armoured vehicle variants, as it prepares for a potential showdown with China.
-
Hanwha signs deals to advance large vehicle programmes in Australia
The deals were announced at Australia’s Land Forces 2024 International Land Defence Exposition in Melbourne and are a further strengthening of the South Korea’s Hanwha’s position in Australia.
-
Defence spending insights: Denmark set to order more CV9035 IFVs
The vehicles, which will form part of a new Heavy Brigade, could see BAE Systems Hägglunds covering the supply of 115 new CV9035 MkIIIC IFVs.